TECH OUTLOOKDecember - 201919of thermal photography, chromameters, ultrasonography, superficial veins detectors, oxygen monitoring, and electric grinder for tablets in both their standard modes as well as in innovative ways.In fact, the crushing of tablets becomes a necessity at times, but the available procedures are extremely elaborate and time-consuming as they need manual intervention, per Simona. "Hence, we have validated a highly standardised procedure using an electric pill grinder, which is much faster and ensures highly reproducible results," she explains. 3S Pharma is also using innovative medical diagnostic technologies like thermal photography for adhesion performance of TDS and highly accurate and automatic adhesion data processing. In the long-acting injectable product section, too, the company has introduced innovation. Since intramuscular products always bear a risk factor if injected in a vein instead of the muscle, 3S Pharma's injectable products are administered under ultrasound control (colour Doppler technology) that eliminates the risk of accidental injection in a vessel. Simona adds, "We are also developing a technique that would assess the distribution on the mucosa of the intra-nasal administered products by computer tomography, and we do perfom the assessment of their local tolerability by nasal endoscopy."Ever since its first clinical trial in 1997, 3S Pharma has never lagged in its focus on safe and scientifically-proven solutions, innovative and high-quality services. In the forthcoming days, the organisation wants to sharpen its focus on immunotherapy and value-added medication. "We believe innovation requires a fresh perspective, and challenging of the status quo. We strive to do this on a daily basis by devising new methods to service our customers. We will continue to abide by our motto: `We search for solutions, you save time and money, and problems are solved'," concludes Simona. We are also developing a technique that would assess the distribution on the mucosa of the intra-nasal administered products by computer tomography, and we do perfom the assessment of their local tolerability by nasal endoscopy
< Page 9 | Page 11 >